
|Articles|June 27, 2023
Opioid Reformulation for Abuse Deterrence - Filed as a CMC Supplement in Less Than a Year
Author(s)Societal CDMO
It is no secret that Opioid abuse is an ongoing public health emergency. Societal™’s client stood at an impasse in pursuit of providing pain relief to patients, while following the recommendation of the FDA to reformulate the product for abuse deterrence.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
From AI to Smart Factories: How Pharma Is Preparing for 2026
2
Industry Outlook 2026: Success through Top Talent, AI Utilization, and Sustainability
3
Pharma Disruption in 2025: A Recap of Our Top 10 Articles
4
HITL and HOTL: An Air Traffic Control Analogy for Agentic AI
5